Kraematon Investment Advisors’s Eli Lilly LLY Stock Holding History

Kraematon Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$762K	Buy	829 +1	+0.1%	+$1.01K	0.62%	51
2025 Q4	$890K	Buy	828 +28	+4%	+$26.8K	0.71%	40
2025 Q3	$611K	Sell	800 -113	-12%	-$84.1K	0.52%	54
2025 Q2	$711K	Sell	913 -141	-13%	-$110K	0.67%	48
2025 Q1	$870K	Sell	1,054 -97	-8%	-$80.7K	0.89%	36
2024 Q4	$889K	Buy	1,151 +1	+0.1%	+$828	0.88%	39
2024 Q3	$1.02M	Buy	1,150 +155	+16%	+$139K	1%	34
2024 Q2	$901K	Sell	995 -24	-2%	-$19.2K	0.92%	37
2024 Q1	$793K	Buy	1,019 +40	+4%	+$28.5K	0.8%	42
2023 Q4	$571K	Buy	+979	New	+$571K	0.63%	47
2023 Q1	–	Sell	-168	Closed	-$61.5K	–	171
2022 Q4	$61.5K	Buy	+168	New	+$59.6K	0.07%	120

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kraematon Investment Advisors's LLY Position: Q1 2026 in Review

Kraematon Investment Advisors increased its Eli Lilly (LLY) stake by 0.12% in Q1 2026, buying an estimated $1.01K and bringing the position to 829 shares worth $762K. The position accounts for 0.62% of the portfolio, ranked #51.

Kraematon Investment Advisors first reported a position in LLY in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.02M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Kraematon Investment Advisors held 829 shares of Eli Lilly worth $762K as of Q1 2026.
Kraematon Investment Advisors bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
Eli Lilly made up 0.62% of Kraematon Investment Advisors's portfolio in Q1 2026, its #51 holding.
Kraematon Investment Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 11 quarters since.
Kraematon Investment Advisors's Eli Lilly position peaked at $1.02M in Q3 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kraematon Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.